Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jia-Yin Yao

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 1, 2024
ReplyXiang Peng, Jia-Yin Yao, Min Zhang, et al.
World Journal of Gastroenterology|February 25, 2020
Development of a prognostic model for one-year surgery risk in Crohn's disease patients: A retrospective studyJia-Yin Yao, Yi Jiang, Jia Ke, et al.
Frontiers in Medicine|November 21, 2024
Changes in clinical features and seasonal variations of Crohn's disease at diagnosis: a 10-year observational study in ChinaJun Deng, Yi Lu, Tao Liu, et al.
Hepato-Gastroenterology|August 12, 2011
Successful treatment with danhong injection for hepatic veno-occlusive diseaseJia-Yin Yao, Min Zhi, Wu-Teng Cao, et al.
Chinese Medical Journal|March 3, 2011
Screening of specific binding peptide targeting blood vessel of human esophageal cancer in vivo in miceMin Zhi, Kai-chun Wu, Zhi-ming Hao, et al.
Molecular Medicine Reports|July 30, 2014
Inhibition of the interleukin-23/interleukin-17 pathway by anti-interleukin-23p19 monoclonal antibody attenuates 2,4,6-trinitrobenzene sulfonic acid-induced Crohn's disease in ratsJia Yin Yao, Yi Lu, Min Zhi, et al.
Journal of Ovarian Research|February 8, 2023
Clinical characteristics and risk factors of ovarian reserve decreases in women with Crohn's disease: a case-control studyPeng Xiang, Jia-Yin Yao, Xiao-Lan Li, et al.
Gastroenterology Report|October 26, 2022
The efficacy and safety of thalidomide in the treatment of refractory Crohn's disease in adults: a double-center, double-blind, randomized-controlled trialXiang Peng, Zi-Wen Lin, Min Zhang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 3, 2024
Efficacy and Safety of Vonoprazan-Amoxicillin Dual Regimen With Varying Dose and Duration for Helicobacter pylori Eradication: A Multicenter, Prospective, Randomized StudyXiang Peng, Jia-Yin Yao, Yu-Qian Ma, et al.
Clinical and Experimental Medicine|April 28, 2023
Combination of vonoprazan and amoxicillin as the first-line Helicobacter pylori eradication therapy: a multicenter, prospective, randomized, parallel-controlled studyXiang Peng, Huang-Wei Chen, Yu Wan, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 1, 2024
ReplyXiang Peng, Jia-Yin Yao, Min Zhang, et al.
World Journal of Gastroenterology|February 25, 2020
Development of a prognostic model for one-year surgery risk in Crohn's disease patients: A retrospective studyJia-Yin Yao, Yi Jiang, Jia Ke, et al.
Frontiers in Medicine|November 21, 2024
Changes in clinical features and seasonal variations of Crohn's disease at diagnosis: a 10-year observational study in ChinaJun Deng, Yi Lu, Tao Liu, et al.
Hepato-Gastroenterology|August 12, 2011
Successful treatment with danhong injection for hepatic veno-occlusive diseaseJia-Yin Yao, Min Zhi, Wu-Teng Cao, et al.
Chinese Medical Journal|March 3, 2011
Screening of specific binding peptide targeting blood vessel of human esophageal cancer in vivo in miceMin Zhi, Kai-chun Wu, Zhi-ming Hao, et al.
Molecular Medicine Reports|July 30, 2014
Inhibition of the interleukin-23/interleukin-17 pathway by anti-interleukin-23p19 monoclonal antibody attenuates 2,4,6-trinitrobenzene sulfonic acid-induced Crohn's disease in ratsJia Yin Yao, Yi Lu, Min Zhi, et al.
Journal of Ovarian Research|February 8, 2023
Clinical characteristics and risk factors of ovarian reserve decreases in women with Crohn's disease: a case-control studyPeng Xiang, Jia-Yin Yao, Xiao-Lan Li, et al.
Gastroenterology Report|October 26, 2022
The efficacy and safety of thalidomide in the treatment of refractory Crohn's disease in adults: a double-center, double-blind, randomized-controlled trialXiang Peng, Zi-Wen Lin, Min Zhang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 3, 2024
Efficacy and Safety of Vonoprazan-Amoxicillin Dual Regimen With Varying Dose and Duration for Helicobacter pylori Eradication: A Multicenter, Prospective, Randomized StudyXiang Peng, Jia-Yin Yao, Yu-Qian Ma, et al.
Clinical and Experimental Medicine|April 28, 2023
Combination of vonoprazan and amoxicillin as the first-line Helicobacter pylori eradication therapy: a multicenter, prospective, randomized, parallel-controlled studyXiang Peng, Huang-Wei Chen, Yu Wan, et al.
Pageof 2